A variant in GRIA4, the gene that codes for the subunit 4 of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor, showed genome-wide significance for association with ND–MD comorbidity. This evidence concerns the gene GRIA4 and Menkes disease.